EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Role of DaT-SPECT Imaging in the Evaluation of Progressive Supranuclear Palsy

Alexandros Giannakis iD, Konstantina Pakou, Spyridon Konitsiotis iD, Chrissa Sioka iD

Life · 01.06.2026 · 16 (6) · 936

DOI: 10.3390/life16060936 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Life, online erschienen am 01.06.2026. Verfasst von Alexandros Giannakis und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Faculty of Medicine, School of Health Sciences, University of Ioannina, University Campus, Stavrou Niarchou Av., 45500 Ioann…. Die Arbeit nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Progressive supranuclear palsy (PSP) is an atypical Parkinsonian disorder characterized by a range of clinical phenotypes, reflecting its multiple subtypes. As a result, accurate diagnosis during life remains challenging, underscoring the need for reliable biomarkers. The present narrative review aims to evaluate whether dopamine transporter single-photon emission computed tomography (DaT-SPECT) can serve as a biomarker in the assessment of PSP.

Methods

The database search identified 31 original research articles relevant to our study objective. Of these, 17 studies included PSP patients and utilized DaT-SPECT as the sole molecular imaging modality; 9 studies combined DaT-SPECT with at least one additional molecular imaging technique; and 5 studies integrated DaT-SPECT with a laboratory-based biomarker of neurodegenerative disease.

Results

DaT-SPECT appears to demonstrate low specificity and variable sensitivity for PSP across studies.

Discussion

Combining DaT-SPECT with other diagnostic biomarkers, especially brain magnetic resonance imaging and other nuclear imaging modalities, may improve diagnostic accuracy, especially given its relatively low specificity for PSP. Nevertheless, these initially promising findings need to be validated in large, multicenter studies that include and clearly define multiple, autopsy-confirmed PSP subtypes.

Schlagwörter

Stichwörter der Autor:innen

basal gangliadopamine transporterprogressive supranuclear palsysingle-photon emission computed tomography

Autor:innen und Institutionen

  • Department of Neurology, Faculty of Medicine, School of Health Sciences, University of Ioannina, University Campus, Stavrou Niarchou Av., 45500 Ioannina, Greece.
  • Department of Nuclear Medicine, Faculty of Medicine, School of Health Sciences, University of Ioannina, University Campus, Stavrou Niarchou Av., 45500 Ioannina, Greece.

ORCID-Profile: Alexandros Giannakis, Spyridon Konitsiotis, Chrissa Sioka

Zitieren

APA

Giannakis, A., Pakou, K., Konitsiotis, S., & Sioka, C. (2026). The Role of DaT-SPECT Imaging in the Evaluation of Progressive Supranuclear Palsy. Life, 16(6), 936. https://doi.org/10.3390/life16060936

Vancouver

Giannakis A, Pakou K, Konitsiotis S, Sioka C. The Role of DaT-SPECT Imaging in the Evaluation of Progressive Supranuclear Palsy. Life. 2026;16(6):936. doi:10.3390/life16060936

BibTeX
@article{Giannakis2026,
  author = {Giannakis, Alexandros and Pakou, Konstantina and Konitsiotis, Spyridon and Sioka, Chrissa},
  title = {The Role of DaT-SPECT Imaging in the Evaluation of Progressive Supranuclear Palsy},
  journal = {Life},
  year = {2026},
  volume = {16},
  number = {6},
  pages = {936},
  doi = {10.3390/life16060936}
}
Kostenlos starten →